Peers of CRISPR Therapeutics AG (CRSP)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by sales over the last 12 months. Like P/S, but also accounts for the company’s debt and cash.
Latest EV/Sales
228.19x
As of Oct 22, 2026
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Oct 22, 2026 | 228.19x |
| Oct 21, 2026 | 231.72x |
| Oct 20, 2026 | 227.25x |
| Oct 19, 2026 | 228.40x |
| Oct 16, 2026 | 222.70x |
| Oct 15, 2026 | 239.08x |
| Oct 14, 2026 | 229.70x |
| Oct 13, 2026 | 228.84x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison